Involvement of mesenchymal stem cells in cancer progression and metastases

Astra I. Chang, Aaron H. Schwertschkow, Jan Nolta, Jian Wu

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Mesenchymal stem/stromal cells (MSCs) are known to be the helpers for the healing of tissue damage, often referred to as ambulatory cells. However, MSCs are also recruited by cancer cells to similarly aid in tumor growth and progression. In this review, some of the key steps in cancer progression and metastases are described including the various steps in which MSCs participate and may play important roles. MSCs aid in cancer cells’ ability to evade immune attack, while promoting tumor angiogenesis, even being counter-acting against chemotherapeutics and other drugs used to fight various cancers. Furthermore, MSCs participate in many of the crucial steps in invasion and metastasis, including stimulating the epithelial-mesenchymal transition (EMT) and induction of stem-like properties that allow cancer stem cells to increase their survivability through the circulation. These steps are described in detail. Differences between circulating tumor cells (CTCs) and cancer stem cells (CSCs) are discussed, along with descriptions of the formation of a pre-metastatic niche, the role of exosomes from both cancer cells and MSCs in metastasis and tumor reseeding (self-seeding). More and more, MSCs are being proposed as a promising tumor targeting drug-delivery tool. In order to fulfill this promise, further understanding of the precise roles that MSCs play in the process of cancer metastases must be achieved, in attempting to create remedies that will improve the outcome of available therapeutics.

Original languageEnglish (US)
Pages (from-to)88-98
Number of pages11
JournalCurrent Cancer Drug Targets
Volume15
Issue number2
StatePublished - 2015

Fingerprint

Mesenchymal Stromal Cells
Neoplasm Metastasis
Neoplasms
Neoplastic Stem Cells
Exosomes
Circulating Neoplastic Cells
Epithelial-Mesenchymal Transition
Drug Delivery Systems

Keywords

  • Cancer metastasis
  • Cancer stem cells
  • Circulating tumor cells
  • Exosomes
  • Mesenchymal stem cells
  • Microenvironment

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Cancer Research

Cite this

Involvement of mesenchymal stem cells in cancer progression and metastases. / Chang, Astra I.; Schwertschkow, Aaron H.; Nolta, Jan; Wu, Jian.

In: Current Cancer Drug Targets, Vol. 15, No. 2, 2015, p. 88-98.

Research output: Contribution to journalArticle

Chang, AI, Schwertschkow, AH, Nolta, J & Wu, J 2015, 'Involvement of mesenchymal stem cells in cancer progression and metastases', Current Cancer Drug Targets, vol. 15, no. 2, pp. 88-98.
Chang, Astra I. ; Schwertschkow, Aaron H. ; Nolta, Jan ; Wu, Jian. / Involvement of mesenchymal stem cells in cancer progression and metastases. In: Current Cancer Drug Targets. 2015 ; Vol. 15, No. 2. pp. 88-98.
@article{f2c9266f89aa4b3e8301ad0804c076ec,
title = "Involvement of mesenchymal stem cells in cancer progression and metastases",
abstract = "Mesenchymal stem/stromal cells (MSCs) are known to be the helpers for the healing of tissue damage, often referred to as ambulatory cells. However, MSCs are also recruited by cancer cells to similarly aid in tumor growth and progression. In this review, some of the key steps in cancer progression and metastases are described including the various steps in which MSCs participate and may play important roles. MSCs aid in cancer cells’ ability to evade immune attack, while promoting tumor angiogenesis, even being counter-acting against chemotherapeutics and other drugs used to fight various cancers. Furthermore, MSCs participate in many of the crucial steps in invasion and metastasis, including stimulating the epithelial-mesenchymal transition (EMT) and induction of stem-like properties that allow cancer stem cells to increase their survivability through the circulation. These steps are described in detail. Differences between circulating tumor cells (CTCs) and cancer stem cells (CSCs) are discussed, along with descriptions of the formation of a pre-metastatic niche, the role of exosomes from both cancer cells and MSCs in metastasis and tumor reseeding (self-seeding). More and more, MSCs are being proposed as a promising tumor targeting drug-delivery tool. In order to fulfill this promise, further understanding of the precise roles that MSCs play in the process of cancer metastases must be achieved, in attempting to create remedies that will improve the outcome of available therapeutics.",
keywords = "Cancer metastasis, Cancer stem cells, Circulating tumor cells, Exosomes, Mesenchymal stem cells, Microenvironment",
author = "Chang, {Astra I.} and Schwertschkow, {Aaron H.} and Jan Nolta and Jian Wu",
year = "2015",
language = "English (US)",
volume = "15",
pages = "88--98",
journal = "Current Cancer Drug Targets",
issn = "1568-0096",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Involvement of mesenchymal stem cells in cancer progression and metastases

AU - Chang, Astra I.

AU - Schwertschkow, Aaron H.

AU - Nolta, Jan

AU - Wu, Jian

PY - 2015

Y1 - 2015

N2 - Mesenchymal stem/stromal cells (MSCs) are known to be the helpers for the healing of tissue damage, often referred to as ambulatory cells. However, MSCs are also recruited by cancer cells to similarly aid in tumor growth and progression. In this review, some of the key steps in cancer progression and metastases are described including the various steps in which MSCs participate and may play important roles. MSCs aid in cancer cells’ ability to evade immune attack, while promoting tumor angiogenesis, even being counter-acting against chemotherapeutics and other drugs used to fight various cancers. Furthermore, MSCs participate in many of the crucial steps in invasion and metastasis, including stimulating the epithelial-mesenchymal transition (EMT) and induction of stem-like properties that allow cancer stem cells to increase their survivability through the circulation. These steps are described in detail. Differences between circulating tumor cells (CTCs) and cancer stem cells (CSCs) are discussed, along with descriptions of the formation of a pre-metastatic niche, the role of exosomes from both cancer cells and MSCs in metastasis and tumor reseeding (self-seeding). More and more, MSCs are being proposed as a promising tumor targeting drug-delivery tool. In order to fulfill this promise, further understanding of the precise roles that MSCs play in the process of cancer metastases must be achieved, in attempting to create remedies that will improve the outcome of available therapeutics.

AB - Mesenchymal stem/stromal cells (MSCs) are known to be the helpers for the healing of tissue damage, often referred to as ambulatory cells. However, MSCs are also recruited by cancer cells to similarly aid in tumor growth and progression. In this review, some of the key steps in cancer progression and metastases are described including the various steps in which MSCs participate and may play important roles. MSCs aid in cancer cells’ ability to evade immune attack, while promoting tumor angiogenesis, even being counter-acting against chemotherapeutics and other drugs used to fight various cancers. Furthermore, MSCs participate in many of the crucial steps in invasion and metastasis, including stimulating the epithelial-mesenchymal transition (EMT) and induction of stem-like properties that allow cancer stem cells to increase their survivability through the circulation. These steps are described in detail. Differences between circulating tumor cells (CTCs) and cancer stem cells (CSCs) are discussed, along with descriptions of the formation of a pre-metastatic niche, the role of exosomes from both cancer cells and MSCs in metastasis and tumor reseeding (self-seeding). More and more, MSCs are being proposed as a promising tumor targeting drug-delivery tool. In order to fulfill this promise, further understanding of the precise roles that MSCs play in the process of cancer metastases must be achieved, in attempting to create remedies that will improve the outcome of available therapeutics.

KW - Cancer metastasis

KW - Cancer stem cells

KW - Circulating tumor cells

KW - Exosomes

KW - Mesenchymal stem cells

KW - Microenvironment

UR - http://www.scopus.com/inward/record.url?scp=84931041679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931041679&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 88

EP - 98

JO - Current Cancer Drug Targets

JF - Current Cancer Drug Targets

SN - 1568-0096

IS - 2

ER -